157 related articles for article (PubMed ID: 11333903)
1. Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody.
Israel BF; Pickles RJ; Segal DM; Gerard RD; Kenney SC
J Virol; 2001 Jun; 75(11):5215-21. PubMed ID: 11333903
[TBL] [Abstract][Full Text] [Related]
2. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
[TBL] [Abstract][Full Text] [Related]
3. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
Von Seggern DJ; Huang S; Fleck SK; Stevenson SC; Nemerow GR
J Virol; 2000 Jan; 74(1):354-62. PubMed ID: 10590124
[TBL] [Abstract][Full Text] [Related]
5. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
7. Direct B/B-cell interactions in immunoglobulin synthesis.
Shinozaki K; Yasui K; Agematsu K
Clin Exp Immunol; 2001 Jun; 124(3):386-91. PubMed ID: 11472398
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.
Rea D; Havenga MJ; van Den Assem M; Sutmuller RP; Lemckert A; Hoeben RC; Bout A; Melief CJ; Offringa R
J Immunol; 2001 Apr; 166(8):5236-44. PubMed ID: 11290808
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
10. Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor.
Vasiljevic S; Beale EV; Bonomelli C; Easthope IS; Pritchard LK; Seabright GE; Caputo AT; Scanlan CN; Dalziel M; Crispin M
Mol Immunol; 2015 Dec; 68(2 Pt A):234-43. PubMed ID: 26391350
[TBL] [Abstract][Full Text] [Related]
11. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
12. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
13. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT
Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M
Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053
[TBL] [Abstract][Full Text] [Related]
15. Efficient transduction of murine B lymphocytes and B lymphoma lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins.
Li L; Wickham TJ; Keegan AD
Gene Ther; 2001 Jun; 8(12):938-45. PubMed ID: 11426334
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
Becker Y; Tabor E; Asher Y
Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
[TBL] [Abstract][Full Text] [Related]
17. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
18. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
Subklewe M; Sebelin K; Block A; Meier A; Roukens A; Paludan C; Fonteneau JF; Steinman RM; Münz C
Hum Immunol; 2005 Sep; 66(9):938-49. PubMed ID: 16360833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
